Insights

Innovative Bioprinting Solutions Allevi's development of the first desktop 3D bioprinter capable of printing living tissues with human cells positions the company as a leader in accessible, versatile bioprinting technology. This offers significant sales opportunities with research labs, medical institutions, and biotech firms seeking cutting-edge tools for tissue engineering and regenerative medicine.

Expanding Product Portfolio Recent launches such as bioink kits for multi-layered skin cells and ultraviolet light sensors demonstrate Allevi's commitment to diversifying its product line. This opens avenues for cross-selling to existing customers interested in advanced bioinks and sensors for various biomedical applications.

Strategic Scientific Leadership The appointment of a Chief Scientific Officer and ongoing research initiatives indicate a focus on innovation and credibility, making the company attractive to research institutions and biotech firms looking for trusted partners to support experimental and scalable bioprinting projects.

Global Research Community Serving hundreds of laboratories worldwide, Allevi has built a strong user base engaged in high-impact research. Engaging this community further through targeted sales and collaborations can facilitate adoption of new products and expand market reach.

Funding and Market Position With modest revenue and recent funding of $1 million, Allevi is positioned as a growth-stage innovator. Collaborations, strategic sales efforts, and customized solutions to niche biotech players can accelerate revenue growth and establish a more competitive presence in the bioprinting industry.

BioBots Tech Stack

BioBots uses 8 technology products and services including Squarespace, WordPress, oEmbed, and more. Explore BioBots's tech stack below.

  • Squarespace
    Content Management System
  • WordPress
    Content Management System
  • oEmbed
    Dev Tools
  • Modernizr
    Javascript Libraries
  • pickadate.js
    Javascript Libraries
  • Intercom
    Live Chat
  • Yoast SEO
    Search Engines
  • WooCommerce Subscriptions
    Wordpress Plugins

Media & News

BioBots's Email Address Formats

BioBots uses at least 1 format(s):
BioBots Email FormatsExamplePercentage
First@allevi3d.comJohn@allevi3d.com
44%
Last@allevi3d.comDoe@allevi3d.com
8%
First.Last@allevi3d.comJohn.Doe@allevi3d.com
4%
First@allevi3d.comJohn@allevi3d.com
44%

Frequently Asked Questions

Where is BioBots's headquarters located?

Minus sign iconPlus sign icon
BioBots's main headquarters is located at 3401 Grays Ferry Ave Philadelphia, PA 19146 US. The company has employees across 2 continents, including North AmericaAfrica.

What is BioBots's phone number?

Minus sign iconPlus sign icon
You can contact BioBots's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioBots's official website and social media links?

Minus sign iconPlus sign icon
BioBots's official website is allevi3d.com and has social profiles on LinkedIn.

What is BioBots's SIC code NAICS code?

Minus sign iconPlus sign icon
BioBots's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioBots have currently?

Minus sign iconPlus sign icon
As of September 2025, BioBots has approximately 11 employees across 2 continents, including North AmericaAfrica. Key team members include Co-Captain, Finance Manager, Programmer, Engineer: V. V.. Explore BioBots's employee directory with LeadIQ.

What industry does BioBots belong to?

Minus sign iconPlus sign icon
BioBots operates in the Biotechnology Research industry.

What technology does BioBots use?

Minus sign iconPlus sign icon
BioBots's tech stack includes SquarespaceWordPressoEmbedModernizrpickadate.jsIntercomYoast SEOWooCommerce Subscriptions.

What is BioBots's email format?

Minus sign iconPlus sign icon
BioBots's email format typically follows the pattern of First@allevi3d.com. Find more BioBots email formats with LeadIQ.

How much funding has BioBots raised to date?

Minus sign iconPlus sign icon
As of September 2025, BioBots has raised $1M in funding. The last funding round occurred on Nov 01, 2019 for $1M.

When was BioBots founded?

Minus sign iconPlus sign icon
BioBots was founded in 2014.

BioBots

Biotechnology ResearchPennsylvania, United States11-50 Employees

Allevi builds tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity's most difficult problems - to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life.

Founded in 2014, our mission is to make it easy to design and engineer 3D tissues.  We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to serve hundreds of labs in all corners of the world and have become leaders in the biofabrication revolution. Allevi 3D bioprinters, software, and bioinks print 3D living tissues one layer at a time.

We are constantly inspired by our community of users who are performing world-class research on our platform. When your work has life-changing implications for people all over the world, it’s an amazing responsibility. That ingenuity. That importance. That’s Allevi. We believe everyone has the potential to change the course of medicine.

Section iconCompany Overview

Headquarters
3401 Grays Ferry Ave Philadelphia, PA 19146 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M

    BioBots has raised a total of $1M of funding over 10 rounds. Their latest funding round was raised on Nov 01, 2019 in the amount of $1M.

  • $1M

    BioBots's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    BioBots has raised a total of $1M of funding over 10 rounds. Their latest funding round was raised on Nov 01, 2019 in the amount of $1M.

  • $1M

    BioBots's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.